1. 19P Effects of CTLA-4 single nucleotide polymorphisms (SNPs) on toxicity of ipilimumab-containing regimens in patients with advanced stage melanoma. (December 2022) Authors: Joode, K.D.; Rojas Mora, A.; Van Schaik, R.; Zippelius, A.; Van der Veldt, A.A.M.; Gerard, C.L.; Läubli, H.; Michielin, O.A.; von Moos, R.A.F.; Joerger, M.; Levesque, M.P.; Aeppli, S.; Mangana, J.; Mangas, C.; Meyer, S.; Leoni-Parvex, S.; Mathijssen, R.H.; Metaxas, Y. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 243P Skin biopsies for pharmacodynamic studies of tebentafusp: A novel bispecific molecule against the melanocytic antigen gp100. (December 2022) Authors: Stäger, R.; Tastanova, A.; Ramelyte, E.; Levesque, M.P.; Dummer, R.; Meier-Schiesser, B. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 3349 Hedgehog pathway inhibitors promote adaptive immune responses in basal cell carcinoma. (September 2015) Authors: Otsuka, A.; Dreier, J.; Cheng, P.; Nägeli, M.; Levesque, M.P.; Dummer, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S685 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. An exploratory study investigating the metabolic activity and local cytokine profile in patients with melanoma treated with pazopanib and paclitaxel. (19th September 2016) Authors: Thurneysen, S.; Cheng, P.F.; Nagel, H.W.; Kunz, M.; Jaberg‐Bentele, N.; Nägeli, M.; Ziegler, M.; Guenova, E.; Goldinger, S.M.; Mangana, J.; Levesque, M.P.; Dummer, R. Journal: British journal of dermatology Issue: Volume 175:Number 5(2016) Page Start: 966 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. An exploratory study investigating the metabolic activity and local cytokine profile in patients with melanoma treated with pazopanib and paclitaxel. (1st November 2016) Authors: Thurneysen, S.; Cheng, P.F.; Nagel, H.W.; Kunz, M.; Jaberg‐Bentele, N.; Nägeli, M.; Ziegler, M.; Guenova, E.; Goldinger, S.M.; Mangana, J.; Levesque, M.P.; Dummer, R. Journal: British journal of dermatology Issue: Volume 175:Number 5(2016) Page Start: 966 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Basal cell carcinomas in a tertiary referral centre: a systematic analysis. (1st November 2014) Authors: Dreier, J.; Cheng, P.F.; Bogdan Alleman, I.; Gugger, A.; Hafner, J.; Tschopp, A.; Goldinger, S.M.; Levesque, M.P.; Dummer, R. Journal: British journal of dermatology Issue: Volume 171:Number 5(2014:Nov.) Page Start: 1066 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Basal cell carcinomas in a tertiary referral centre: a systematic analysis. (20th October 2014) Authors: Dreier, J.; Cheng, P.F.; Bogdan Alleman, I.; Gugger, A.; Hafner, J.; Tschopp, A.; Goldinger, S.M.; Levesque, M.P.; Dummer, R. Journal: British journal of dermatology Issue: Volume 171:Number 5(2014:Nov.) Page Start: 1066 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Basal cell carcinomas in a tertiary referral centre: a systematic analysis. (20th October 2014) Authors: Dreier, J.; Cheng, P.F.; Bogdan Alleman, I.; Gugger, A.; Hafner, J.; Tschopp, A.; Goldinger, S.M.; Levesque, M.P.; Dummer, R. Journal: British journal of dermatology Issue: Volume 171:Number 5(2014:Nov.) Page Start: 1066 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Increased tumour cell PD‐L1 expression, macrophage and dendritic cell infiltration characterise the tumour microenvironment of ulcerated primary melanomas. (26th November 2018) Authors: Koelblinger, P.; Emberger, M.; Drach, M.; Cheng, P.F.; Lang, R.; Levesque, M.P.; Bauer, J.W.; Dummer, R. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 4(2019) Page Start: 667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Inhibition of oncogenic MAPK signaling in melanoma triggers SOX2-dependent adaptive drug resistance programs. (July 2016) Authors: Flueckiger, S.; Aloia, A.; Frischknecht, L.; Tuozzo, A.; Croci, D.; Shakhova, O.; Britschgi, C.; Levesque, M.P.; Dummer, R.; Krek, W. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗